Compare AANJANEYA LIFECARE with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS FDC LTD. DR. DATSONS LABS/
FDC LTD.
 
P/E (TTM) x -10.9 15.0 - View Chart
P/BV x 0.2 2.6 6.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   FDC LTD.
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
FDC LTD.
Mar-18
DR. DATSONS LABS/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs126319 39.4%   
Low Rs31164 18.8%   
Sales per share (Unadj.) Rs133.061.6 215.7%  
Earnings per share (Unadj.) Rs0.29.9 1.5%  
Cash flow per share (Unadj.) Rs6.612.0 55.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.873.2 176.0%  
Shares outstanding (eoy) m31.66174.40 18.2%   
Bonus/Rights/Conversions FCCBBB-  
Price / Sales ratio x0.63.9 15.0%   
Avg P/E ratio x516.124.3 2,126.3%  
P/CF ratio (eoy) x11.820.2 58.7%  
Price / Book Value ratio x0.63.3 18.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47742,118 5.9%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m562,167 2.6%   
Avg. sales/employee Rs ThNM1,943.7-  
Avg. wages/employee Rs ThNM391.7-  
Avg. net profit/employee Rs ThNM313.7-  
INCOME DATA
Net Sales Rs m4,21110,751 39.2%  
Other income Rs m79510 15.4%   
Total revenues Rs m4,28911,260 38.1%   
Gross profit Rs m5692,267 25.1%  
Depreciation Rs m204351 58.2%   
Interest Rs m43014 3,072.9%   
Profit before tax Rs m132,411 0.5%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6671 0.9%   
Profit after tax Rs m51,735 0.3%  
Gross profit margin %13.521.1 64.0%  
Effective tax rate %48.027.8 172.5%   
Net profit margin %0.116.1 0.7%  
BALANCE SHEET DATA
Current assets Rs m6,8527,213 95.0%   
Current liabilities Rs m6,7112,104 319.0%   
Net working cap to sales %3.347.5 7.0%  
Current ratio x1.03.4 29.8%  
Inventory Days Days16154 295.2%  
Debtors Days Days31828 1,148.7%  
Net fixed assets Rs m3,6736,865 53.5%   
Share capital Rs m317175 180.7%   
"Free" reserves Rs m3,76112,586 29.9%   
Net worth Rs m4,07812,761 32.0%   
Long term debt Rs m1,6716 27,846.7%   
Total assets Rs m12,63315,041 84.0%  
Interest coverage x1.0173.2 0.6%   
Debt to equity ratio x0.40 87,150.0%  
Sales to assets ratio x0.30.7 46.6%   
Return on assets %3.411.6 29.6%  
Return on equity %0.113.6 0.9%  
Return on capital %7.719.0 40.5%  
Exports to sales %22.912.3 185.5%   
Imports to sales %14.30-   
Exports (fob) Rs m9641,327 72.7%   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9641,889 51.0%   
Fx outflow Rs m6070-   
Net fx Rs m3571,889 18.9%   
CASH FLOW
From Operations Rs m1,3451,498 89.7%  
From Investments Rs m-2,256201 -1,121.6%  
From Financial Activity Rs m-1,200-1,694 70.8%  
Net Cashflow Rs m-2,11110 -20,492.2%  

Share Holding

Indian Promoters % 4.5 68.9 6.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 1.4 7.5 18.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.0 495.3%  
Shareholders   20,807 23,730 87.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  ASTRAZENECA PHARMA  DIVIS LABORATORIES  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed(Closing)

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

Related Views on News

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Real Long-Term Impact of the Coronavirus on India(The 5 Minute Wrapup)

Mar 18, 2020

My view on the impact of the Coronavirus on the Indian economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS